AI
MGNX icon

Atom Investors’s MacroGenics MGNX Stock Holding History

Atom Investors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-78,005
Closed -$332K – 549
2024
Q2 		$332K Sell
78,005
-26,840
-26% -$261K 0.03% 368
2024
Q1 		$1.54M Sell
104,845
-34,245
-25% -$518K 0.19% 168
2023
Q4 		$1.34M Buy
139,090
+109,441
+369% +$757K 0.24% 138
2023
Q3 		$138K Buy
+29,649
New +$148K 0.03% 397
2022
Q4 		– Sell
-46,048
Closed -$159K – 282
2022
Q3 		$159K Buy
+46,048
New +$176K 0.06% 225
2021
Q2 		– Sell
-55,863
Closed -$1.78M – 303
2021
Q1 		$1.78M Sell
55,863
-101,589
-65% -$2.47M 0.3% 74
2020
Q4 		$3.6M Buy
157,452
+114,723
+268% +$2.64M 0.36% 72
2020
Q3 		$1.08M Buy
42,729
+7,800
+22% +$213K 0.1% 183
2020
Q2 		$975K Buy
+34,929
New +$607K 0.06% 209

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Atom Investors's MGNX Position: Q3 2024 in Review

Atom Investors sold out of MacroGenics (MGNX) in Q3 2024, closing a stake of 78,005 shares — an estimated $332K sold.

Atom Investors first reported a position in MGNX in Q2 2020 and held it in 9 quarters. The position peaked at $3.6M in Q4 2020. 124 funds tracked by Wall St. Rank hold MGNX as of Q3 2024.

  • Atom Investors reported no remaining MacroGenics position as of Q3 2024 after selling out during the quarter.
  • Atom Investors sold 78,005 MacroGenics shares in Q3 2024, an estimated $332K.
  • Atom Investors first reported a position in MacroGenics in Q2 2020 and held it in 9 quarters.
  • Atom Investors's MacroGenics position peaked at $3.6M in Q4 2020.
  • 124 funds tracked by Wall St. Rank held MacroGenics as of Q3 2024.

Based on Atom Investors's 13F filing for Q3 2024, filed 14 Nov 2024.